| abstract |
The invention relates to homogeneous recombinant human interleukin-1α polypeptides, DNA sequences which code for such polypeptides, recombinant vectors which contain such a DNA, host organisms which contain such a recombinant vector and methods for producing the said polypeptides. The homogeneous recombinant human interleukin-1α polypeptides and pharmaceutical compositions containing such polypeptides can be used to stimulate a patient's immune system, promote wound healing, or promote recovery from seriously ill, protein-malnourished patients. |